Kevin Lee

CIK: 0001776938

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)17 (89.5%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (10.5%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

BCYC

BICYCLE THERAPEUTICS PLC

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (19 total)

BCYC
BICYCLE THERAPEUTICS PLC
Oct 5, 2026
Sale(S)
Direct
1.6K shares at avg. $3.57$6K
BCYC
BICYCLE THERAPEUTICS PLC
Oct 2, 2026
Sale(S)
Direct
6.2K shares at avg. $3.47$21K
BCYC
BICYCLE THERAPEUTICS PLC
Jul 6, 2026
Sale(S)
Direct
1.7K shares at avg. $4.31$7K
BCYC
BICYCLE THERAPEUTICS PLC
Jul 2, 2026
Sale(S)
Direct
5.9K shares at avg. $4.27$25K
BCYC
BICYCLE THERAPEUTICS PLC
Apr 6, 2026
Sale(S)
Direct
1.7K shares at avg. $5.05$9K
BCYC
BICYCLE THERAPEUTICS PLC
Apr 2, 2026
Sale(S)
Direct
6K shares at avg. $4.91$29K
BCYC
BICYCLE THERAPEUTICS PLC
Jan 5, 2026
Sale(S)
Direct
11K shares at avg. $6.46$71K
BCYC
BICYCLE THERAPEUTICS PLC
Jan 2, 2026
Award(A)
Direct
165K shares-
BCYC
BICYCLE THERAPEUTICS PLC
Jan 2, 2026
Sale(S)
Direct
10.3K shares at avg. $6.80$70K
BCYC
BICYCLE THERAPEUTICS PLC
Oct 3, 2025
Sale(S)
Direct
3.2K shares at avg. $8.41$27K
BCYC
BICYCLE THERAPEUTICS PLC
Oct 2, 2025
Sale(S)
Direct
2.3K shares at avg. $8.40$19K
BCYC
BICYCLE THERAPEUTICS PLC
Jul 3, 2025
Sale(S)
Direct
3.2K shares at avg. $7.44$24K
BCYC
BICYCLE THERAPEUTICS PLC
Jul 2, 2025
Sale(S)
Direct
2.3K shares at avg. $7.09$16K
BCYC
BICYCLE THERAPEUTICS PLC
Apr 3, 2025
Sale(S)
Direct
3.4K shares at avg. $7.48$26K
BCYC
BICYCLE THERAPEUTICS PLC
Apr 2, 2025
Sale(S)
Direct
2.2K shares at avg. $8.02$18K
BCYC
BICYCLE THERAPEUTICS PLC
Jan 3, 2025
Sale(S)
Direct
3.1K shares at avg. $14.75$46K
BCYC
BICYCLE THERAPEUTICS PLC
Jan 2, 2025
Award(A)
Direct
123.2K shares-
BCYC
BICYCLE THERAPEUTICS PLC
Jan 2, 2025
Sale(S)
Direct
9K shares at avg. $14.09$127K
BCYC
BICYCLE THERAPEUTICS PLC
Oct 3, 2024
Sale(S)
Direct
3.2K shares at avg. $22.26$71K

		Type	Shares	Price		Ownership
Oct 5, 2026	BCYC BICYCLE THERAPEUTICS PLC	Sale(S)	1,638	$3.57	$5,848	Direct
Oct 2, 2026	BCYC BICYCLE THERAPEUTICS PLC	Sale(S)	6,167	$3.47	$21,399	Direct
Jul 6, 2026	BCYC BICYCLE THERAPEUTICS PLC	Sale(S)	1,737	$4.31	$7,486	Direct
Jul 2, 2026	BCYC BICYCLE THERAPEUTICS PLC	Sale(S)	5,905	$4.27	$25,214	Direct
Apr 6, 2026	BCYC BICYCLE THERAPEUTICS PLC	Sale(S)	1,716	$5.05	$8,666	Direct
Apr 2, 2026	BCYC BICYCLE THERAPEUTICS PLC	Sale(S)	5,967	$4.91	$29,298	Direct
Jan 5, 2026	BCYC BICYCLE THERAPEUTICS PLC	Sale(S)	10,989	$6.46	$70,989	Direct
Jan 2, 2026	BCYC BICYCLE THERAPEUTICS PLC	Award(A)	165,000	-	$0	Direct
Jan 2, 2026	BCYC BICYCLE THERAPEUTICS PLC	Sale(S)	10,325	$6.80	$70,210	Direct
Oct 3, 2025	BCYC BICYCLE THERAPEUTICS PLC	Sale(S)	3,231	$8.41	$27,173	Direct
Oct 2, 2025	BCYC BICYCLE THERAPEUTICS PLC	Sale(S)	2,263	$8.40	$19,009	Direct
Jul 3, 2025	BCYC BICYCLE THERAPEUTICS PLC	Sale(S)	3,193	$7.44	$23,756	Direct
Jul 2, 2025	BCYC BICYCLE THERAPEUTICS PLC	Sale(S)	2,268	$7.09	$16,080	Direct
Apr 3, 2025	BCYC BICYCLE THERAPEUTICS PLC	Sale(S)	3,432	$7.48	$25,671	Direct
Apr 2, 2025	BCYC BICYCLE THERAPEUTICS PLC	Sale(S)	2,237	$8.02	$17,941	Direct
Jan 3, 2025	BCYC BICYCLE THERAPEUTICS PLC	Sale(S)	3,092	$14.75	$45,607	Direct
Jan 2, 2025	BCYC BICYCLE THERAPEUTICS PLC	Award(A)	123,200	-	$0	Direct
Jan 2, 2025	BCYC BICYCLE THERAPEUTICS PLC	Sale(S)	9,038	$14.09	$127,345	Direct
Oct 3, 2024	BCYC BICYCLE THERAPEUTICS PLC	Sale(S)	3,212	$22.26	$71,499	Direct

1-19 of 19 transactions

About Lee Kevin

Lee Kevin (SEC CIK 0001776938) files insider reports with the SEC as CHIEF EXECUTIVE OFFICER of BICYCLE THERAPEUTICS PLC (BCYC).

Signal8 holds 9 ownership filings by Lee Kevin, all Form 4s, filed between Oct 4, 2024 and Oct 6, 2026. Those filings report 19 transactions, from Oct 3, 2024 to Oct 5, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Lee Kevin's filings is in CAMBRIDGE.

Recent filings by Lee Kevin

Oct 5, 2026: Open-market sale of BCYC shares (Form 4, code S).
Oct 2, 2026: Open-market sale of BCYC shares (Form 4, code S).
Jul 6, 2026: Open-market sale of BCYC shares (Form 4, code S).
Jul 2, 2026: Open-market sale of BCYC shares (Form 4, code S).
Apr 6, 2026: Open-market sale of BCYC shares (Form 4, code S).

Other insiders filing for BICYCLE THERAPEUTICS PLC (BCYC)

Perry Jennifer Scott, Chief Operating Officer
Swanton Robert Charles, Director
Skynner Michael, CHIEF SCIENTIFIC OFFICER
Hannay Michael Charles Ferguson, CHIEF PROD & SUPPLY CHAIN OFF
Thompson Travis Alvin, Chief Financial Officer
Milnes Alistair, CHIEF OPERATING OFFICER

How to read Form 4 transaction codes